Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders

Research output: Contribution to journalReview article

7 Scopus citations


Diagnosing neurodegenerative diseases, monitoring their progression and assessing responses to treatments will all be aided by the identification of molecular markers of different stages of pathology. Protein biomarkers for HIV-associated neurocognitive disorders that have been discovered using proteomics include complement C3, soluble superoxide dismutase and a prostaglandin synthase. Metabolomics has not yet been widely used for biomarker discovery, but early work shows that it has great potential.

Original languageEnglish (US)
Article number1756
JournalGenome Medicine
Issue number3
Publication statusPublished - Mar 30 2010


ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this